The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
about
Anaesthesia for patient with chronic obstructive pulmonary diseaseDoes this patient really have chronic obstructive pulmonary disease?The pharmacological approach to the elderly COPD patient.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.Acute and Chronic Effects of Oral Erdosteine on Ciliary Beat Frequency, Cough Sensitivity and Airway Reactivity.
P2860
The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The evidence for the use of or ...... tive pulmonary disease (COPD).
@en
The evidence for the use of or ...... obstructive pulmonary disease
@nl
type
label
The evidence for the use of or ...... tive pulmonary disease (COPD).
@en
The evidence for the use of or ...... obstructive pulmonary disease
@nl
prefLabel
The evidence for the use of or ...... tive pulmonary disease (COPD).
@en
The evidence for the use of or ...... obstructive pulmonary disease
@nl
P356
P1476
The evidence for the use of or ...... tive pulmonary disease (COPD).
@en
P2093
P M A Calverley
P304
P356
10.1093/BMB/LDP050
P577
2009-12-22T00:00:00Z